These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18297152)

  • 21. A report from the 46th Annual Meeting of the European Association for the Study of Diabetes (September 20-24, 2010 - Stockholm, Sweden).
    Rabasseda X
    Drugs Today (Barc); 2011 Jan; 47(1):77-95. PubMed ID: 21373651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 23. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic medications in pregnancy.
    Young J; Anwar A
    Curr Diabetes Rev; 2009 Nov; 5(4):252-8. PubMed ID: 19925389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes: an expanded view of pathophysiology and therapy.
    Unger J; Parkin CG
    Postgrad Med; 2010 May; 122(3):145-57. PubMed ID: 20463424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Diabetes Association - 67th scientific sessions.
    Filson S
    IDrugs; 2007 Sep; 10(9):600-2. PubMed ID: 17786837
    [No Abstract]   [Full Text] [Related]  

  • 27. Beyond glycemic control: treating the entire type 2 diabetes disorder.
    Brunton S
    Postgrad Med; 2009 Sep; 121(5):68-81. PubMed ID: 19820276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating incretin-based therapy into type 2 diabetes management.
    Brunton SA
    J Fam Pract; 2013 Jun; 62(6 Suppl CME):S1-8. PubMed ID: 23828807
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic Control in the Treatment of Psoriasis.
    Ip W; Kirchhof MG
    Dermatology; 2017; 233(1):23-29. PubMed ID: 28538228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
    Thornberry NA; Gallwitz B
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of noninsulin antidiabetic medications in hospitalized patients.
    Kopecky C
    Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipeptidyl peptidase-iV inhibitors: fixing type 2 diabetes?
    McIntyre HF; Grant P
    Br J Hosp Med (Lond); 2007 Nov; 68(11):599-602. PubMed ID: 18087847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choosing among the incretin agents and why it matters.
    Unger J
    J Fam Pract; 2010 May; 59(5 Suppl):S30-5. PubMed ID: 20544056
    [No Abstract]   [Full Text] [Related]  

  • 35. Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
    Olansky L
    Cleve Clin J Med; 2010 Aug; 77(8):503-5. PubMed ID: 20682512
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
    Moritoh Y; Takeuchi K; Hazama M
    J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel pharmacologic agents for type 2 diabetes.
    Uwaifo GI; Ratner RE
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incretin therapy and its effect on body weight in patients with diabetes.
    Lind M
    Prim Care Diabetes; 2012 Oct; 6(3):187-91. PubMed ID: 22613745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of GLP-1 agonists and DPP4 inhibitors.
    Tuch BE
    Pancreatology; 2016; 16(1):8-9. PubMed ID: 26138513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatments and devices for future diabetes management.
    Capaldi B
    Nurs Times; 2005 May 3-9; 101(18):30-2. PubMed ID: 15892503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.